Edition:
India

Endologix Inc (ELGX.OQ)

ELGX.OQ on NASDAQ Stock Exchange Global Select Market

5.86USD
22 Jun 2018
Change (% chg)

$0.11 (+1.91%)
Prev Close
$5.75
Open
$5.75
Day's High
$5.94
Day's Low
$5.65
Volume
713,699
Avg. Vol
161,069
52-wk High
$6.71
52-wk Low
$3.75

Select another date:

Thu, May 3 2018

BRIEF-Endologix Reports Q1 Loss Per Share $0.24

* Q1 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S

BRIEF-Endologix Appoints John Onopchenko As Chief Executive Officer

* ENDOLOGIX APPOINTS JOHN ONOPCHENKO AS CHIEF EXECUTIVE OFFICER

BRIEF-Endologix Reports Positive Results From Global Encore Analysis With Polymer Endovascular Aneurysm Repair

* ENDOLOGIX INC - POSITIVE RESULTS FROM GLOBAL ENCORE ANALYSIS WITH POLYMER ENDOVASCULAR ANEURYSM REPAIR USING OVATION ABDOMINAL STENT GRAFT SYSTEMS Source text for Eikon: Further company coverage:

BRIEF-Endologix Inc CEO John McDermott Steps Down

* JOHN MCDERMOTT STEPS DOWN AS CHIEF EXECUTIVE OFFICER OF ENDOLOGIX, INC.

BRIEF-Endologix Posts Q4 Loss Per Share $0.17

* ENDOLOGIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

BRIEF-Endologix Completes Patient Enrollment In The Elevate IDE Clinical Study

* ENDOLOGIX, INC. COMPLETES PATIENT ENROLLMENT IN THE ELEVATE IDE CLINICAL STUDY Source text for Eikon: Further company coverage:

BRIEF-Endologix- On Jan 5, Co Delivered Notice Of Termination To Deerfield Elgx Revolver As Agent Under Credit, Security Agreement Dated As Of April 3, 2017

* ENDOLOGIX- ON JAN 5, CO DELIVERED NOTICE OF TERMINATION TO DEERFIELD ELGX REVOLVER AS AGENT UNDER CREDIT, SECURITY AGREEMENT DATED AS OF APRIL 3, 2017

Select another date: